THE Diabetes DAILYNEWS CONCEPTUAL INDEX
[To View Headlines without Links Click Here]





Therapy of Type 2 Diabetes....


"Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia.....";

"Guava fruit may benefit type 2 diabetics.....";

"Long-Acting GLP-I agonist Exendin-4 Stimulates Both beta-Cell Replication and Neogenesis, Resulting in Increased beta-Cell Mass and Improved Glucose Tolerance in Diabetic Rats....."
Glucagon-Like Peptide 1 and Exendin-4 Convert Pancreatic AR42J Cells Into Glucagon- and Insulin-Producing Cells .....";

"NDC recommends metformin as first line MONOTHERAPY therapy in the OBESE (BMI>30) type 2 patient, but also recommends CAUTION when combining metformin with sulfonylurea agents.......";

"ISRAELI STUDY SHOWS INCREASED MORTALITY WITH METFORMIN- SULFONYLUREA COMBINATION THERAPY.........."; 

"Bristol-Myers Squibb warned about Glucophage adverse event reporting.............";

"FDA foolishly rejects important new antibiotic................";

"GLP-1 is able to normalize plasma glucose in all type 2-diabetic patients studied. This analysis underlines the great therapeutic potential of GLP-1.....";

"Actos (pioglitazone) approval in Type 2s as monotherapy or in combination with metformin, insulin, or SFU's cautioned by edema, weight gain, and anemia but heartened by lowering triglycerides.................";

"Avandia (Rosiglitazone) approval by FDA cautioned by LDL increase, edema, anemia, and weight-gain.............";

"The allele frequency of the PPAR gamma 2 missense mutation Pro12Ala variant is 0.12 in Caucasian Americans, 0.10 in Mexican Americans, 0.08 in Samoans, 0.03 in African Americans, 0.02 in Nauruans............;

"D-chiro-inositol effective in reducing insulin resistance................";

"Beta Cell Failure Gets Almost All Type 2 Diabetics In Time.............";

"Type 2 diabetics will eventually require insulin for good control.........";



Reload The National Diabetes Center Frames
Home Page